At what enterprise value was VERIFARMA acquired in 2026?

You can find the full valuation details of VERIFARMA on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the TMT (Tech, Media, Telecom) industry currently tracks an average EBITDA multiple of 13.4x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of VERIFARMA when it was acquired by MTIP?

The exact EV/EBITDA multiple for VERIFARMA is available on mynth capital. For comparison, the TMT (Tech, Media, Telecom) sector currently shows an average EBITDA multiple of 13.4x. Join our community for free to access full valuation data and industry trends.

When was VERIFARMA acquired by MTIP?

VERIFARMA was acquired by MTIP in 2026.

What was the revenue of VERIFARMA at the time of the deal?

The revenue of VERIFARMA at the time of the deal is estimated to be in the range of 5M - 25M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of VERIFARMA during the acquisition?

VERIFARMA's EBITDA is estimated to be in the range of 0M - 5M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the VERIFARMA acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the VERIFARMA deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.investorsinhealthcare.com/articles/category/news/spain-mtip-makes-strategic-investment-in-verifarma/

← DATABASE

Home Database TMT (Tech, Media, Telecom)VERIFARMA

03/2026

VERIFARMA

Acquired by

MTIP

SPAIN Software / Industry-Specific Software / Healthcare REV 5M - 25M EUR

VERIFARMA acquired by MTIP

SPAIN Software / Industry-Specific Software / Healthcare REV 5M - 25M EUR

Context

MTIP has completed a majority strategic investment in Verifarma, a Spain,headquartered software provider. The transaction is designed to propel the next phase of the company's growth, with a specific focus on international scaling and technological advancement. All four co,founders, including the CEO, CFO, COO, and Chief AI Officer, will continue to lead the business post,investment, ensuring management continuity and the preservation of long,term customer relationships. The strategic rationale for the partnership involves significant investment in the core track,and,trace technology platform and the expansion of AI,driven quality management features. Furthermore, the capital will be used to strengthen the group's go,to,market infrastructure in Europe and to further penetrate the Latin American market. This investment aligns with the growing global demand for rigorous pharmaceutical traceability and regulatory compliance, positioning the organization as a leading international player in the healthtech space. MTIP intends to leverage its extensive experience in scaling healthcare technology companies to support the entity's continued internationalization and platform development.

VERIFARMA, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the TMT (Tech, Media, Telecom) sector (13.4x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Verifarma is a high, growth SaaS provider specializing in integrated serialization, traceability, and regulatory compliance solutions tailored for the pharmaceutical industry. The organization provides an end,to,end software platform that supports pharmaceutical manufacturers, wholesalers, and distributors in navigating complex global traceability requirements. Its technology spans the entire supply chain, ensuring the safety and authenticity of medicines by tracking products from production to the end consumer. Established in 2007, the entity has developed a leading position in the Latin American market and is rapidly expanding its footprint across Europe. With a mission focused on supply chain integrity, the company serves a diverse global client base, leveraging AI,driven capabilities to enhance quality management and track,and,trace efficiency for more than 2,000 companies.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2025

2024

Other operations with VERIFARMA

REFERENCES

Revenue range: 5M - 25M EUR

EBITDA range: 0M - 5M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of VERIFARMA by MTIP are reserved for mynth community members. Register for free to unlock full data.

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Target: verifarma

Acquirer: mtip